The Associated Press has posted an article about the Alabama Supreme Court rejecting a jury’s verdict that would have awarded the state $274 million. The state of Alabama filed the suit was against 3 pharmaceutical companies ( AstraZeneca, Novartis and GlaxoSmithKline).
The state claimed that the drug companies had “fraudulently manipulating prices of drugs for Medicaid recipients.” However, in an 8-1 ruling, the court decided that the state didn’t have to solely rely on the companies’ data to price medication.
The justices said state officials could have done their own research and determined the correct price.The court ruled the state is continuing to rely on the same formulas established by the drug companies to set prices.
“The state has never altered its course of conduct since taking issue with the reporting methods,” said the majority ruling written by Justice Tom Woodall. Justice Tom Parker cast the lone dissent.
If you have experienced issues similar to this, feel free to contact us.